Vinnova

Adsorbi is a developer of innovative bio-based foam constructed from cellulose materials, aimed at capturing air pollutants. This novel biomaterial is designed to absorb pollution in microenvironments, making it suitable for various applications, including the storage and packaging of food, artwork, batteries, books, and personal care products. By utilizing this technology, Adsorbi enables customers to maintain healthier environments, contributing to improved air quality and the protection of valuable items.

BeammWave AB, founded in 2016 and based in Lund, Sweden, specializes in the development of radio frequency integrated chips that facilitate digital beamforming. The company's innovative technology includes a single chip integrating front-end components and antenna arrays specifically designed for mobile phones and Internet of Things (IoT) devices operating in the millimeter-wave spectrum. This technology is particularly relevant for applications in 5G and future communication systems, enabling enhanced connectivity and performance in a variety of devices.

Saab Ventures, established in 2001, is the corporate venture capital arm of Saab AB, headquartered in Stockholm, Sweden. It invests in technology companies, with a focus on those rooted in the defense, civil security, aviation, and space sectors. The firm makes both direct investments in startups and early-stage companies, as well as fund-of-fund investments in venture capital funds. Saab Ventures typically invests between SEK0.1 million and SEK50 million, seeking companies with an enterprise value between SEK40 million and SEK100 million within five years, and existing or potential revenues of SEK100 million within the same period. It prefers minority equity positions and co-investment opportunities, with an investment horizon of four to seven years.

FLOX specializes in wildlife management by leveraging advanced technology and Generative AI to enhance human-wildlife coexistence. The company offers management and deterrence services aimed at minimizing the impact of wildlife in various environments such as agriculture, airports, railways, and public spaces. Utilizing autonomous drones equipped with sophisticated sensors and artificial intelligence, FLOX operates independently to monitor wildlife and optimize management strategies. This innovative approach allows organizations to maintain safer and more productive environments while reducing risks associated with wildlife interactions. By streamlining workflows in wildlife management, FLOX enables clients to focus on their core activities, fostering a harmonious coexistence between humans and wildlife.

Blue Cromos Management AB specializes in providing comprehensive analysis and optimization services for organizations seeking to enhance their operational efficiency and achieve their business objectives. The company offers expertise in operational analysis, process management, and the development of key performance indicators (KPIs). With a focus on business analytics and business intelligence, Blue Cromos Management AB empowers clients to make informed decisions that optimize their return on investment (ROI) and support both short- and long-term goals.

Net Zero Build offers an AI-driven platform designed to streamline and automate the sustainable building certification process. Our AI-powered platform helps real estate project teams navigate certification requirements efficiently and collaborate effectively with all stakeholders involved, significantly enhancing productivity and reducing administrative costs. We aim to empower the real estate industry with the right digital tools to increase their positive environmental impact and contribute to global climate change mitigation efforts.

Beat Vascular Health are revolutionizing cardiovascular diagnostics through non-invasive sensors. advanced signal processing and digital twin-modelling. We aim to enhance early detection and precise localization of cardiovascular diseases (CVD), initially Peripheral Arterial Disease (PAD), one of the most common CVDs.

Enerpoly is an energy storage technology company focused on developing rechargeable zinc-ion battery chemistry. The company aims to create batteries using safe, affordable materials that can be sustainably scaled to promote wider access to clean energy. Enerpoly innovates in battery components, production methods, and designs, utilizing agile research and development techniques to ensure rapid delivery. Their batteries are designed for various applications, including grid, industrial, commercial, and residential uses, making them versatile solutions for energy storage challenges.

XNK Therapeutics is a clinical-stage biotechnology company based in Stockholm, Sweden, specializing in immunotherapy for cancer prevention and treatment. The company develops innovative therapies centered on autologous natural killer (NK) cells utilizing its proprietary technology platform. This platform enables the creation of NK cell-based products that are particularly effective in targeting cancers, especially in scenarios where allogeneic cell therapies may not be suitable. XNK Therapeutics aims to play a pivotal role in advancing cancer treatment strategies through its leading investigational drug candidates and established expertise in the development and manufacture of these specialized therapies.

Beat Vascular Health are revolutionizing cardiovascular diagnostics through non-invasive sensors. advanced signal processing and digital twin-modelling. We aim to enhance early detection and precise localization of cardiovascular diseases (CVD), initially Peripheral Arterial Disease (PAD), one of the most common CVDs.

Ecohelix specializes in the production of innovative amphiphilic polymers derived from lignocellulosic side streams of the pulp industry. Utilizing a patented enzymatic process, the company transforms residual materials such as lignin and hemicellulose into high-performance, biodegradable polymers. Their flagship product, WOODMER®, serves as a sustainable alternative to conventional plastics and fossil-based materials, finding applications in packaging, adhesives, and paper chemicals. By harnessing underutilized raw materials, Ecohelix not only enhances the value of the pulp industry but also contributes to a more sustainable future by significantly reducing CO2 emissions and promoting environmentally friendly practices across various sectors, including packaging, construction, and cosmetics.

Qlucore is a prominent provider of innovative bioinformatics software designed for research and precision diagnostics, focusing on the analysis of complex data generated in genetics and proteomics. The company offers two main products: Qlucore Omics Explorer, a user-friendly bioinformatics tool for researchers in life sciences, biotechnology, and academia, and Qlucore Diagnostics, a platform aimed at companion and precision diagnostics that incorporates AI-powered machine learning classifiers and patient-friendly visualizations. Founded in 2007 by researchers from Lund University in Sweden, Qlucore aims to simplify the interpretation of large datasets, enabling researchers, technicians, and physicians to derive insights efficiently. With a presence in approximately 35 countries and a customer base that includes leading pharmaceutical companies, hospitals, and universities, Qlucore is committed to enhancing data analysis capabilities in the life sciences sector.

Intervacc is a biotechnology company that specializes in developing vaccines based on recombinant proteins for animal health care. The company addresses the growing demand for effective vaccines and also emphasizes diagnostics within the animal health sector. Through its subsidiary, Intervacc provides bacteriological and mycological analyses specifically in the Swedish market.

Johannas Stadsodlingar is a Stockholm-based company that specializes in the production of fish, vegetables, and herbs through sustainable aquaponics systems. This innovative approach creates a mini-ecosystem where fish and natural processes collaborate with plants to enhance growth while minimizing environmental impact and water usage. The company offers a range of products, including salads and spices, all cultivated without toxins, ensuring that customers have access to natural and sustainable food options.

Invivopower specializes in innovative transcutaneous wireless energy transfer technology aimed at improving the quality of life for patients with heart failures. The company develops a unique energy-linked system that allows for the wireless powering of active medical implants, such as artificial hearts and ventricular assist devices, by utilizing a connector that forms the primary winding in a transformer. This technology enables the delivery of energy through intact skin, making it applicable not only for heart-related devices but also for other medical implants, including neural stimulators, retinal implants, cochlear implants, and insulin pumps. By advancing this technology, Invivopower seeks to enhance patient care and extend life for individuals relying on these critical medical devices.

FLOX specializes in wildlife management by leveraging advanced technology and Generative AI to enhance human-wildlife coexistence. The company offers management and deterrence services aimed at minimizing the impact of wildlife in various environments such as agriculture, airports, railways, and public spaces. Utilizing autonomous drones equipped with sophisticated sensors and artificial intelligence, FLOX operates independently to monitor wildlife and optimize management strategies. This innovative approach allows organizations to maintain safer and more productive environments while reducing risks associated with wildlife interactions. By streamlining workflows in wildlife management, FLOX enables clients to focus on their core activities, fostering a harmonious coexistence between humans and wildlife.

Oncopeptides is a biotech company dedicated to the research, development, and commercialization of therapies for challenging hematological diseases. The company is advancing its lead compound, melflufen, a peptide-conjugated alkylator that falls under a new class of drugs called Peptidase Enhanced Compounds. Melflufen is designed to selectively deliver cytotoxic agents directly to cancer cells, thereby enhancing treatment efficacy. Currently, it is undergoing Phase 2 efficacy studies for patients with relapsed and relapsed-refractory multiple myeloma. The unique mechanism of melflufen allows for targeted delivery, as it accumulates in diseased cells, resulting in rapid and irreversible DNA damage through alkylation. This focused approach aims to improve treatment outcomes for patients with difficult-to-treat hematological cancers.

Enerpoly is an energy storage technology company focused on developing rechargeable zinc-ion battery chemistry. The company aims to create batteries using safe, affordable materials that can be sustainably scaled to promote wider access to clean energy. Enerpoly innovates in battery components, production methods, and designs, utilizing agile research and development techniques to ensure rapid delivery. Their batteries are designed for various applications, including grid, industrial, commercial, and residential uses, making them versatile solutions for energy storage challenges.

Johannas Stadsodlingar is a Stockholm-based company that specializes in the production of fish, vegetables, and herbs through sustainable aquaponics systems. This innovative approach creates a mini-ecosystem where fish and natural processes collaborate with plants to enhance growth while minimizing environmental impact and water usage. The company offers a range of products, including salads and spices, all cultivated without toxins, ensuring that customers have access to natural and sustainable food options.

Mycorena AB, founded in 2017 and based in Gothenburg, Sweden, specializes in developing nutritious fungi-based protein as a sustainable alternative to both meat and traditional plant-based proteins. The company leverages fungi biotechnology to create vegan protein products that require significantly fewer resources than conventional food production methods. By focusing on sustainability and resource efficiency, Mycorena aims to address global sustainability challenges and promote a circular economy. Its innovative solutions contribute to a more environmentally friendly food industry, enabling customers to make choices that positively impact the planet.

Johannas Stadsodlingar is a Stockholm-based company that specializes in the production of fish, vegetables, and herbs through sustainable aquaponics systems. This innovative approach creates a mini-ecosystem where fish and natural processes collaborate with plants to enhance growth while minimizing environmental impact and water usage. The company offers a range of products, including salads and spices, all cultivated without toxins, ensuring that customers have access to natural and sustainable food options.

Mentice is a leading provider of virtual reality-based interventional medical simulation solutions, focusing on enhancing the skills of healthcare professionals in various medical fields. The company offers a range of software and hardware solutions tailored for endovascular therapies, including neurovascular, cardiovascular, and peripheral interventions. These solutions are designed to assist healthcare providers in acquiring, retaining, and improving procedural skills, thereby enhancing productivity and patient outcomes. Mentice operates through three primary segments: System Sales, Software Licenses, and Service. The majority of its revenue is generated from the Americas, followed by the Europe, Middle East, and Africa (EMEA) region. The company's offerings are scientifically validated, ensuring their effectiveness in the medical industry.

With Pirr, users can create spicy stories with AI (LLMs). Users can create in private or together with other users, such as a partner or a friend. Users can publish and share their stories, follow and give likes. Pirr has reached more than 300 thousand users without any marketing.

Oncopeptides is a biotech company dedicated to the research, development, and commercialization of therapies for challenging hematological diseases. The company is advancing its lead compound, melflufen, a peptide-conjugated alkylator that falls under a new class of drugs called Peptidase Enhanced Compounds. Melflufen is designed to selectively deliver cytotoxic agents directly to cancer cells, thereby enhancing treatment efficacy. Currently, it is undergoing Phase 2 efficacy studies for patients with relapsed and relapsed-refractory multiple myeloma. The unique mechanism of melflufen allows for targeted delivery, as it accumulates in diseased cells, resulting in rapid and irreversible DNA damage through alkylation. This focused approach aims to improve treatment outcomes for patients with difficult-to-treat hematological cancers.

Compular specializes in the development of advanced analytic tools aimed at the creation of high-tech materials. The company focuses on digital material development, offering simulation and analysis capabilities that predict material properties based on intuitive design principles. Their tools provide actionable insights into the properties of materials and liquids, facilitating the screening of candidate formulations and enhancing mechanistic understanding of material functions. This predictive approach supports research and development processes across various applications, including batteries, fuel cells, metals and alloys, pharmaceuticals, electronics, and chemicals. By leveraging molecular dynamics and density functional theory, Compular aims to improve the success rates of laboratory trials for its clients.

With Pirr, users can create spicy stories with AI (LLMs). Users can create in private or together with other users, such as a partner or a friend. Users can publish and share their stories, follow and give likes. Pirr has reached more than 300 thousand users without any marketing.

Neue is an open innovation organization focused on advancing digital technology and fostering entrepreneurial talent to stimulate economic growth and enhance quality of life. It aims to lower the barriers between prototyping and industrialization within the Internet of Things (IoT) sector through its platform, Neue Playground. This versatile platform serves as a comprehensive solution for developers, designers, and innovators, enabling them to create connected products efficiently. By offering a low-code, end-to-end solution, Neue Playground facilitates the transition from idea to prototype to finished product swiftly. The platform generates firmware, builds cloud functions, and creates web applications, all within a single tool, while leveraging artificial intelligence to support users throughout the development process.

Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden, focused on developing innovative cell and gene therapies for cancer treatment. The company’s portfolio includes four drug candidates: ELC-100 and ELC-201, which are oncolytic virus therapies, and ELC-301 and ELC-401, which are CAR T-cell treatments. Additionally, Elicera has developed a universal CAR T-cell technology platform known as iTANK (ELC-001), designed to enhance the effectiveness of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors.

AirForestry is focused on revolutionizing forest management through the use of electric harvesting drones. This innovative approach allows for thinning forests from the air, which not only reduces carbon dioxide emissions associated with traditional forestry practices but also enhances the forest's capacity to sequester carbon. By freeing up 20% of forest land currently occupied by access roads, AirForestry aims to create healthier forests that contribute to a more sustainable society. The company's technology serves as an efficient harvesting tool, enabling forestry departments to optimize land use and improve carbon storage, thereby playing a significant role in combating climate change.

We are building a decentralized language education platform that allows students and teachers to build personalized and comprehensive learning experiences in record speed.

Royal Schedule is a developer of a cloud-based scheduling platform aimed at streamlining the often complicated and inefficient process of creating work schedules. The platform employs sophisticated algorithms to generate multiple scheduling options within hours, optimizing for minimal working hours while adhering to various user requirements. This automation allows professionals, such as teachers and nurses, to devote more time to their primary responsibilities rather than the intricacies of scheduling. Users can manage their schedules conveniently from any location at any time, enhancing overall efficiency and productivity in their respective fields.

Compular specializes in the development of advanced analytic tools aimed at the creation of high-tech materials. The company focuses on digital material development, offering simulation and analysis capabilities that predict material properties based on intuitive design principles. Their tools provide actionable insights into the properties of materials and liquids, facilitating the screening of candidate formulations and enhancing mechanistic understanding of material functions. This predictive approach supports research and development processes across various applications, including batteries, fuel cells, metals and alloys, pharmaceuticals, electronics, and chemicals. By leveraging molecular dynamics and density functional theory, Compular aims to improve the success rates of laboratory trials for its clients.

Compular specializes in the development of advanced analytic tools aimed at the creation of high-tech materials. The company focuses on digital material development, offering simulation and analysis capabilities that predict material properties based on intuitive design principles. Their tools provide actionable insights into the properties of materials and liquids, facilitating the screening of candidate formulations and enhancing mechanistic understanding of material functions. This predictive approach supports research and development processes across various applications, including batteries, fuel cells, metals and alloys, pharmaceuticals, electronics, and chemicals. By leveraging molecular dynamics and density functional theory, Compular aims to improve the success rates of laboratory trials for its clients.

Johannas Stadsodlingar is a Stockholm-based company that specializes in the production of fish, vegetables, and herbs through sustainable aquaponics systems. This innovative approach creates a mini-ecosystem where fish and natural processes collaborate with plants to enhance growth while minimizing environmental impact and water usage. The company offers a range of products, including salads and spices, all cultivated without toxins, ensuring that customers have access to natural and sustainable food options.

DBtune is a developer of a database tuning platform that enhances system performance by optimizing databases in both cloud and on-premises environments. The platform utilizes machine learning algorithms to customize optimizations based on specific customer workloads and the hardware in use. By applying artificial intelligence, DBtune enables businesses to achieve scalable performance improvements, ultimately reducing the strain on their underlying hardware. This approach allows organizations to move beyond conservative default settings typically found in databases, tailoring parameters to better suit their particular applications and improving overall efficiency.

We are on a mission to empower everyone to take action for a more sustainable and responsible world. We created EveryAct, an internal social platform that boosts employee engagement, amplifies internal CSR communications, and improves company’s overall influence and growth.

InDex Pharmaceuticals AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, focused on developing treatments for ulcerative colitis and other immunological diseases. The company’s lead product, cobitolimod, offers a local anti-inflammatory effect that aids in mucosal healing and alleviates clinical symptoms. Additionally, InDex Pharmaceuticals utilizes its proprietary DNA-based ImmunoModulatory Sequences (DIMS) platform to create drugs aimed at various therapeutic areas, including inflammation and cancer. The company also provides DiBiCol, a diagnostic kit designed to monitor specific biomarkers related to ulcerative colitis and Crohn’s disease from a single colonic biopsy. Founded in 2016, InDex Pharmaceuticals operates as a subsidiary of InDex Pharmaceuticals Holding AB (publ).

TEXEL Energy Storage is a company focused on developing innovative battery technologies aimed at providing cost-competitive energy storage solutions that can compete with fossil fuels. The company specializes in creating hybrid energy storage systems designed to efficiently store energy from renewable sources, particularly concentrated solar power. TEXEL's platform is designed to deliver viable electricity while promoting sustainability through cost-effective and recyclable energy storage solutions. By advancing energy storage technology beyond traditional lithium options, TEXEL aims to play a significant role in integrating renewable energy into the energy market.

Cellink AB is a biotechnology company specializing in bioprinting technologies that enable the 3D printing of human organs and tissue models, aimed at applications in pharmaceutical, cosmetic, and medical research. Founded in 2016 and headquartered in Gothenburg, Sweden, with an office in Palo Alto, California, Cellink offers a range of products including bioprinters, imaging systems, dispensing solutions, and bioinks that cater to the needs of researchers and laboratories worldwide. Its product lineup features various bioprinting platforms such as BIO X and BIO X6, along with specialized solutions for skin and cartilage tissue, microfluidics, and single-cell dispensing technologies. Cellink’s bioinks are utilized for diverse applications including drug screening, tissue regeneration, and organoids. The company serves a global customer base that includes universities, hospitals, and public laboratories, and it has established collaborations with organizations like MedImmune and Made In Space, Inc., to further its mission of advancing bioprinting technology in medicine.

STILFOLD is a company focused on transforming high-value industries through its innovative origami folding technology, which integrates machine learning and origami engineering. By utilizing industrial origami, STILFOLD employs robotic arms to fold steel sheets, resulting in lighter and stronger products while minimizing material use and carbon emissions. This manufacturing technique not only reduces the number of parts needed but also supports the development of more efficient and sustainable transportation solutions. Through its advanced software and hardware, STILFOLD aims to lead the way in green manufacturing and product development, helping customers create environmentally friendly vehicles and other applications.

Jaisy Health is a company based in Stockholm, Sweden, that specializes in developing jaundice detection equipment aimed at providing a low-cost and highly accurate solution for non-invasive jaundice assessment in infants. Founded in 2018, Jaisy Health utilizes advanced technology to create an optical mobile device that connects to smartphones. This device measures bilirubin levels and predicts the risk of jaundice, enabling timely and accessible detection regardless of location or time. By focusing on affordability and accuracy, Jaisy Health offers an innovative approach to managing jaundice in newborns.

Redsense Medical AB develops and markets advanced safety systems for medical treatments, focusing primarily on the dialysis sector in Europe and the United States. The company's flagship product, the Redsense System, utilizes patented fiber optic sensors to detect blood leakage during hemodialysis, triggering visual and audible alarms to alert caregivers and ensuring prompt response to potential issues. This system also monitors venous needle dislodgement at the blood access site. Additionally, Redsense Medical is working on the Redsense Clamp, an accessory designed to automatically stop blood flow by clamping the blood line in the event of a leak. Founded in 2000 and headquartered in Halmstad, Sweden, Redsense Medical aims to enhance patient safety and care in dialysis treatment through innovative technology.

xNomad operates an online marketplace that connects brands with short-term retail spaces for pop-up stores. The platform provides an innovative end-to-end solution, facilitating access to vacant retail locations while offering additional services such as design, furniture, and staffing. By utilizing data on footfall, demographics, and customer engagement, xNomad assists brands in selecting optimal store locations and measuring the success of their pop-up experiences. This comprehensive approach enables clients to establish their temporary retail presence efficiently and effectively, streamlining the process of creating a unique shopping environment.

Vycellix, Inc., a privately-held company, specializes in the development of innovative cell-based immunotherapeutic products. Its primary focus is to address and overcome the limitations of existing cell and gene therapies, aiming to enhance patient outcomes in the field.

Mendi is a company based in Stockholm, Sweden, established in 2018, that specializes in developing an at-home Neurofeedback Brain Training headband paired with a mobile application. This innovative device aims to enhance mental well-being by helping users improve focus, regulate emotions, and build mental resilience. The headband provides a user-friendly experience, allowing individuals to engage in unlimited mental training sessions, thereby promoting better mental health and performance. Mendi's approach combines hardware and software to create a comprehensive solution for individuals seeking to strengthen their cognitive abilities and overall mental health.

Price Edge is developing the dream pricing software - a cloud based price management tool for enterprises, that give them access to new pricing strategies and more flexibility than ever before. Price Edge is working with many of the largest brands in the world and we have recently started to ramp up our global growth. We are a young, energetic team pursuing the vision of building a global B2B SaaS company that will fundamentally change the way enterprises work with pricing.

Elsa Science AB, founded in 2017 and based in Stockholm, Sweden, operates a digital health platform focused on rheumatoid arthritis. The company empowers patients to take an active role in their healthcare by providing tools that facilitate personal research into their condition. Through its application, users can monitor symptoms, diet, and lifestyle factors, gaining insights into how these elements influence their disease activity. Elsa collaborates with the Riskminder foundation and scientific studies at Karolinska Institutet to deliver reliable data and research findings. By enabling patients to track their responses to medications and overall health status, Elsa supports healthcare professionals in managing chronic diseases more effectively, improving treatment personalization and proactive care.

Royal Schedule is a developer of a cloud-based scheduling platform aimed at streamlining the often complicated and inefficient process of creating work schedules. The platform employs sophisticated algorithms to generate multiple scheduling options within hours, optimizing for minimal working hours while adhering to various user requirements. This automation allows professionals, such as teachers and nurses, to devote more time to their primary responsibilities rather than the intricacies of scheduling. Users can manage their schedules conveniently from any location at any time, enhancing overall efficiency and productivity in their respective fields.

Elsa Science AB, founded in 2017 and based in Stockholm, Sweden, operates a digital health platform focused on rheumatoid arthritis. The company empowers patients to take an active role in their healthcare by providing tools that facilitate personal research into their condition. Through its application, users can monitor symptoms, diet, and lifestyle factors, gaining insights into how these elements influence their disease activity. Elsa collaborates with the Riskminder foundation and scientific studies at Karolinska Institutet to deliver reliable data and research findings. By enabling patients to track their responses to medications and overall health status, Elsa supports healthcare professionals in managing chronic diseases more effectively, improving treatment personalization and proactive care.

Yolean AB is a company based in Gothenburg, Sweden, that specializes in developing visual management tools aimed at facilitating digital Lean transformation. The company provides software that integrates wall-based visual management techniques with backend data management, enabling project line and knowledge managers, as well as Lean transformation leaders, to enhance visibility and transparency in knowledge work. Yolean's software allows for real-time interaction across multiple screens, facilitating collaboration among team members from various locations or organizations. Additionally, it helps identify and quantify bottlenecks in workflows. The company's product offerings include visual planning tools, pulse solutions, and check sheets, serving clients primarily in the automotive and public sectors. Through its focus on Lean visual management and knowledge management, Yolean aims to support businesses in achieving continuous, data-driven improvements in their project management processes.

TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.

Grönska is a young, Swedish tech-company that develops technology for vertical farming, and grows and sells vegetables and herbs. Vertical farming that is based on the use of LED lighting and hydroponic watering systems. This method allows us to grow food indoors, locally and all year round. The reason we do this is to offer a sustainable, locally grown alternative to imported food and to enable more self-sufficient cities. Grönska was founded in 2014 and constructed the largest vertical farm in the Nordics in 2018.

Johannas Stadsodlingar is a Stockholm-based company that specializes in the production of fish, vegetables, and herbs through sustainable aquaponics systems. This innovative approach creates a mini-ecosystem where fish and natural processes collaborate with plants to enhance growth while minimizing environmental impact and water usage. The company offers a range of products, including salads and spices, all cultivated without toxins, ensuring that customers have access to natural and sustainable food options.

Bintel AB is a Swedish company founded in 2018, specializing in the development and marketing of innovative sensors for waste management. Their primary product is a digital waste-management platform that includes sensors mounted on household waste bins, which notify waste collectors when containers are full. This technology enhances the efficiency of waste collection by directly communicating with route planning tools used by waste trucks, helping municipalities, recycling companies, and real estate businesses optimize their collection routes and reduce operational costs. Based in Helsingborg, Bintel aims to improve waste management practices through its advanced sensor technology.

DeviceRadio AB, founded in 2016 and based in Malmö, Sweden, specializes in developing a communication layer that facilitates data transfer across various devices and connectivity methods within the Internet of Things (IoT) ecosystem. The company's innovative solution allows seamless communication regardless of the connection type, including Bluetooth, cellular networks, WiFi, and SMS. DeviceRadio addresses the complexity and fragmentation in the IoT landscape by providing a common infrastructure that enables diverse devices to communicate effectively. This initiative not only simplifies the development process for thousands of developers but also aims to enhance the potential applications of IoT, such as improving emergency response times and agricultural efficiency. Through its efforts, DeviceRadio strives to create a more integrated and cohesive environment for IoT advancements.

Spago Nanomedical AB is a Swedish company engaged in the research and development of nanomaterials for cancer diagnosis and treatment. Founded in 2007 and based in Lund, the company specializes in innovative products designed to enhance cancer care. Its flagship offerings include SpagoPix, a tumor-selective contrast agent aimed at improving cancer diagnosis through magnetic resonance imaging, and Tumorad, a novel radionuclide therapy that delivers targeted radiation to tumor tissues. The development of these products is grounded in a platform of polymeric materials, which enables precise diagnosis and treatment of life-threatening diseases. Spago Nanomedical's advancements hold promise for more effective cancer therapies, focusing on both early detection and targeted treatment options.

Enerpoly is an energy storage technology company focused on developing rechargeable zinc-ion battery chemistry. The company aims to create batteries using safe, affordable materials that can be sustainably scaled to promote wider access to clean energy. Enerpoly innovates in battery components, production methods, and designs, utilizing agile research and development techniques to ensure rapid delivery. Their batteries are designed for various applications, including grid, industrial, commercial, and residential uses, making them versatile solutions for energy storage challenges.

Imagimob AB, based in Stockholm, Sweden, specializes in developing artificial intelligence products focused on movement analytics for both people and objects. The company's flagship offering, SensorBeat, is a comprehensive motion intelligence system that integrates hardware and software components, including sensors, firmware, and artificial intelligence capabilities. This technology enables real-time AI processing on edge devices, facilitating applications such as audio classification, gesture recognition, predictive maintenance, and fall detection. By providing a robust platform, Imagimob allows companies to efficiently create and deploy AI applications tailored for embedded devices, enhancing their operational capabilities and performance.

Deedster is a digital platform that promotes sustainable consumption by helping users track their carbon footprints based on their everyday activities. It encourages individuals to challenge themselves and others to adopt more sustainable habits, thereby fostering a community committed to environmental responsibility. By providing tools and insights, Deedster enables users to make informed choices that contribute to a more sustainable lifestyle.

Beactica Therapeutics AB is a precision oncology company focused on developing innovative small molecule therapeutics for genetically defined cancers that lack effective treatment options. The company utilizes a molecular interaction-based drug discovery platform to identify and target disease proteins with synthetic lethality vulnerabilities. This approach includes the creation of allosteric modulators and targeted protein degraders (PROTACs). Beactica's aim is to enhance treatment outcomes for patients by advancing its drug candidates into early clinical trials. Additionally, the company's platform offers protein-based therapeutics that help regulate disease-associated proteins, thereby improving the immune system's ability to combat cancer while minimizing risks for patients.

MetaboGen is a research and development company focused on biomarker identification and personalized treatment services. The company specializes in metagenomic data analysis, which it combines with development and clinical programs to enhance the understanding of bacterial strains related to specific health indications. By identifying and improving these bacterial strains, MetaboGen aims to support the probiotic industry in creating innovative diagnostic tests and therapeutic solutions.

TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.

DeviceRadio AB, founded in 2016 and based in Malmö, Sweden, specializes in developing a communication layer that facilitates data transfer across various devices and connectivity methods within the Internet of Things (IoT) ecosystem. The company's innovative solution allows seamless communication regardless of the connection type, including Bluetooth, cellular networks, WiFi, and SMS. DeviceRadio addresses the complexity and fragmentation in the IoT landscape by providing a common infrastructure that enables diverse devices to communicate effectively. This initiative not only simplifies the development process for thousands of developers but also aims to enhance the potential applications of IoT, such as improving emergency response times and agricultural efficiency. Through its efforts, DeviceRadio strives to create a more integrated and cohesive environment for IoT advancements.

Abliva AB is a Swedish pharmaceutical company focused on the research and development of treatments for primary mitochondrial diseases, which are rare and severe conditions caused by dysfunctional mitochondria. The company's pipeline includes KL1333, currently in phase I clinical trials, and NV354, an energy replacement therapy that is preparing for clinical trials. KL1333 is noted for its role as a regulator of NAD+ and NADH, and has received orphan drug designation in both Europe and the United States. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injury. Established in 2000 and headquartered in Lund, Sweden, Abliva has formed collaborations with various institutions, enhancing its research capabilities and clinical development efforts.

Mimerse, founded in 2014, specializes in developing evidence-based treatments utilizing immersive technologies, particularly virtual reality (VR). The company collaborates with leading universities and hospitals to create psychological treatment applications for clinicians and researchers. Mimerse has achieved a significant milestone by being the first to clinically validate an automatic VR treatment for specific phobias. Its platform aims to enhance mental wellness and provide effective management solutions for mental health challenges, catering to both professionals and consumers.

Ximantis aims for Smart/Green and Integrated transport by demonstrating a revolutionary road traffic prediction method based on collecting and analyzing “big data” in order to greatly reduce CO2 emissions, decrease overall congestion impact and optimize navigation - the equivalent of a weather forecast for traffic flow and congestion! In addition, Ximantis innovates on advanced vehicle software systems for Connected Cars and Autonomous Navigation through their deep learning Stochastic Re-construction Module, offering safe reaction and anticipation to eminent risk.

MyVox is a company focused on advancing human-machine interaction through innovative technology. The firm specializes in developing a next-generation speaker platform that leverages piezoelectric and silicon membranes, which oscillate and emit ultrasound waves when subjected to an alternating current field. This disruptive technology is designed for micro-electro-mechanical systems and aims to enhance the electronics industry by providing a more effective means of communication between humans and machines. MyVox's team comprises experienced engineers and serial entrepreneurs dedicated to driving progress in deep tech solutions.

RightPrice AI is a Stockholm-based company specializing in e-commerce pricing solutions through advanced artificial intelligence and deep learning technologies. The firm has developed a price optimization platform that automatically processes data from web traffic, sales, and competitor feeds using proprietary machine learning algorithms. By analyzing visitor behavior and product data, RightPrice AI provides businesses with pricing recommendations designed to maximize profit margins and simplify the pricing process. This innovative approach enables companies to predict optimal prices and improve their competitive positioning in the market.

First Derm is iDoc24 Inc product, that has been developed from 4 years of scientific medical research. It allows anyone (B2C, B2B2C and B2B) to anonymously submit images of skin/hair/nail concerns directly to a vetted board certified dermatologist and within hours receive an on what it is and what to do next. We have users in 160 countries and in 7 languages. To date we have found over 500 skin cancer lesions, 1000s of STDs and general skin/hair/nail concerns. Available on iOS, Android, and web.

Ximantis aims for Smart/Green and Integrated transport by demonstrating a revolutionary road traffic prediction method based on collecting and analyzing “big data” in order to greatly reduce CO2 emissions, decrease overall congestion impact and optimize navigation - the equivalent of a weather forecast for traffic flow and congestion! In addition, Ximantis innovates on advanced vehicle software systems for Connected Cars and Autonomous Navigation through their deep learning Stochastic Re-construction Module, offering safe reaction and anticipation to eminent risk.

Gleechi AB, founded in 2014 and based in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interactions between humans, computers, and robots. The company has created a pioneering software product that allows for real-time hand motion interaction, enhancing user experiences in virtual reality and gaming, as well as enabling advanced interaction capabilities for robotic hands. Gleechi's innovations are rooted in sophisticated computer vision and machine learning algorithms. The company has received notable accolades, including the Super Startup of the Year award from Veckans Affärer and ALMI Invest, the EIT Digital Idea Challenge in Europe, and the Startup of the Year award from STING (Stockholm Innovation & Growth).

InDex Pharmaceuticals AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, focused on developing treatments for ulcerative colitis and other immunological diseases. The company’s lead product, cobitolimod, offers a local anti-inflammatory effect that aids in mucosal healing and alleviates clinical symptoms. Additionally, InDex Pharmaceuticals utilizes its proprietary DNA-based ImmunoModulatory Sequences (DIMS) platform to create drugs aimed at various therapeutic areas, including inflammation and cancer. The company also provides DiBiCol, a diagnostic kit designed to monitor specific biomarkers related to ulcerative colitis and Crohn’s disease from a single colonic biopsy. Founded in 2016, InDex Pharmaceuticals operates as a subsidiary of InDex Pharmaceuticals Holding AB (publ).

Fundler AB is a Swedish company that provides a digital platform for private investors to manage their savings portfolios automatically. Founded in 2015 and based in Stockholm, the company operates as a robo-adviser, offering a tailored model of funds and exchange-traded funds that align with each customer's investment horizon, financial situation, risk profile, goals, knowledge, and experience. Fundler's platform facilitates the automation of investment management, allowing users to receive financial advice, access investment information, and execute buy or sell orders directly through the app. By combining low-cost index funds with optimized risk strategies, Fundler enables users to invest according to their individual requirements, thereby enhancing their ability to grow savings effectively.

Winfoor has developed Triblade, a new and groundbreaking technology for large scale wind turbine rotor blades, that can disrupt the entire wind power industry. The patent pending technology is a 3-in-1-blade that will reduce production cost and transport cost dramatically, while allowing rotor blades to be longer, stronger and much lighter than what is possible today. These are game changing improvements that gives Winfoor a unique opportunity in today’s global wind turbine rotor blade market. The technology can also play a decisive role in the development of next generation of larger, more powerful wind turbines and to accelerate the transition to greater use of renewables worldwide.

Bokio AB, founded in 2015 and based in Gothenburg, Sweden, specializes in developing and marketing accounting software that leverages artificial intelligence. The company provides solutions for bookkeeping, invoicing, and payroll services, making accounting accessible to small business owners, particularly in the UK. Its platform automates various financial processes, allowing users to efficiently manage their finances in one place. Additionally, Bokio serves as a marketplace for supplementary services that assist small business owners in simplifying their operations, including finding optimal insurance and pension solutions. The company also collaborates with partners to offer services like invoice sales to enhance liquidity and facilitates the sending of payslips and invoices through conventional mail, encompassing printing, envelopes, and postage.

Beactica Therapeutics AB is a precision oncology company focused on developing innovative small molecule therapeutics for genetically defined cancers that lack effective treatment options. The company utilizes a molecular interaction-based drug discovery platform to identify and target disease proteins with synthetic lethality vulnerabilities. This approach includes the creation of allosteric modulators and targeted protein degraders (PROTACs). Beactica's aim is to enhance treatment outcomes for patients by advancing its drug candidates into early clinical trials. Additionally, the company's platform offers protein-based therapeutics that help regulate disease-associated proteins, thereby improving the immune system's ability to combat cancer while minimizing risks for patients.

VBN Components specializes in the 3D printing of wear-resistant metal components, utilizing patented additive manufacturing techniques to produce free-form components that enhance performance and reduce environmental impact. By focusing on optimal material properties, VBN develops innovative materials that surpass traditional limitations imposed by conventional metalworking methods such as forging and rolling. Their advanced production processes not only minimize metal waste but also accelerate production times, allowing various industries to benefit from high-performance, geometrically complex parts. VBN Components aims to redefine the possibilities of metal manufacturing, delivering superior materials that contribute to the longevity and efficiency of end products.

Saplo is a company specializing in automatic text analytics, employing advanced semantic technologies to analyze and interpret text in a manner similar to human reading. It offers five key services designed to help organizations extract valuable insights from extensive text collections. These services include Entity Tagging, which identifies and categorizes entities such as companies, people, and locations; Topic Tags, which allows users to categorize texts based on identified topics, even if those topics are not explicitly present; Related & Similar Articles, which assesses the semantic relationships between articles; Contextual Recognition, enabling the definition and matching of personalized textual contexts; and Sentiment Analysis, which evaluates emotional content expressed in texts. Saplo provides these capabilities to produce public reports, custom services for clients, and an API for developers. The company participated in Seedcamp Week in 2008, reflecting its commitment to innovation in text analysis.

Beactica Therapeutics AB is a precision oncology company focused on developing innovative small molecule therapeutics for genetically defined cancers that lack effective treatment options. The company utilizes a molecular interaction-based drug discovery platform to identify and target disease proteins with synthetic lethality vulnerabilities. This approach includes the creation of allosteric modulators and targeted protein degraders (PROTACs). Beactica's aim is to enhance treatment outcomes for patients by advancing its drug candidates into early clinical trials. Additionally, the company's platform offers protein-based therapeutics that help regulate disease-associated proteins, thereby improving the immune system's ability to combat cancer while minimizing risks for patients.